🇺🇸 FDA
Patent

US 10544406

Characterization of four prophage endolysins specific for clostridium perfringens

granted A61KA61K35/74A61K38/47

Quick answer

US patent 10544406 (Characterization of four prophage endolysins specific for clostridium perfringens) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K35/74, A61K38/47, A61K9/0053, A61P